Since China’s entry into WTO in 2001, many Japanese, American and European pharmaceutical companies have been changing their raw ingredient and intermediate merchandise production processes to China. “Creation outsourcing has educated Chinese businesses a valuable lesson regarding international practices, environmental awareness, quality control and patent protection, which has greatly enhanced our competitiveness and international status.” Yu thought that behind the OEM orders and gains, medicine exports from China have to beat the hurdles of product quality breakthrough and international standard integration.If you have lots of food export to china,you need to find the best Chinese import agents.
General Manager Mr Ouyang Qing, said that in terms of macro aspects, market access rules for medications between important foreign markets and the Chinese market are not dissimilar. The distinction lies in detailed administrative aspects, including certification, risk assessment and changeable products. Yu also stressed so as to maintain the equilibrium of product qualities that apart from finished product certification, some overseas markets would require associated documentation of ingredients.
According to Mr Ouyang, Shenzhen Lijian was formerly in the business of exporting ingredient drugs, whose quality that is great had acquired a long-term order for a German firm. When Lijian decided to expand mr’s valued-adding medicine production business, that German firm was at the same time contemplating shifting their OEM preparation production from France and Italy to lower-cost markets.There are lots of food export to china, you can find the best on cnbuyers.net.
And the secret to Reachall’s fast FDA approval in US was the option of merchandises. Compound polymyxin B ointment is an OTC (over the counter) product and the FDA had in-depth conditions on education, the ointment’s quality and tagging. This ointment was popular and had gained acceptance in regard to effectiveness and security. Reachall on the other hand, was the first business in China to create the generic variant of the ointment, and the business had embraced FDA standards when it was applying for support in China.
To participate in international competition, the Chinese pharmaceutical sector has to make efforts in English communication skills, support system integration, merchandise selection and R&D. Company supervisors should also provide long term preparation, instead of being opportunistic.With the best Chinese import agents,your business about food export to china will getting better.
Mr Yu also thought that you will see a growing number of Chinese pharmaceutical companies entering important international markets. But Yu reminded that there are going to be a brand new degree of assortment and price rivalry for acquiring multinational commissioned processing contracts in China. The biggest advantages for Chinese firms are their low costs and quality that is satisfactory, but the profitability will gradually decline as a growing number of followers attempting to take a bit of the cake.